AG

Artal Group Portfolio holdings

AUM $930M
1-Year Est. Return 3.57%
This Quarter Est. Return
1 Year Est. Return
-3.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.12B
AUM Growth
+$1.44B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
139
New
Increased
Reduced
Closed

Top Buys

1
+$1.31B
2
+$63.6M
3
+$38.1M
4
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$20.4M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$18.7M

Top Sells

1
+$61.1M
2
+$15.8M
3
+$15.1M
4
FATE icon
Fate Therapeutics
FATE
+$14.8M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$13.1M

Sector Composition

1 Healthcare 56.49%
2 Consumer Discretionary 42.78%
3 Technology 0.24%
4 Financials 0.2%
5 Real Estate 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$2.65M 0.08%
1,542,954
77
$2.54M 0.08%
850,000
78
$2.38M 0.07%
400,000
79
$2.13M 0.07%
2,255,375
80
$1.78M 0.06%
+7,500
81
$1.48M 0.05%
1,000,000
82
$1.3M 0.04%
+10,000
83
$1.18M 0.04%
450,000
84
$1.18M 0.04%
110,532
85
$1.16M 0.04%
33,050
86
$1.15M 0.04%
500,000
87
$1.08M 0.03%
65,000
88
$1.05M 0.03%
+1,133,775
89
$1.02M 0.03%
+3,000
90
$952K 0.03%
1,440,882
91
$710K 0.02%
100,000
92
$683K 0.02%
+6,000
93
$656K 0.02%
2,971
-310
94
$572K 0.02%
138,955
-1
95
$514K 0.02%
+3,500
96
$492K 0.02%
+5,000
97
$479K 0.01%
+4,000
98
$479K 0.01%
22,822
-6,137
99
$448K 0.01%
105,347
100
$436K 0.01%
5,028
-26,939
2 3
4
5 6